In order to study if the vasodilatory action of insulin is impaired in essential hypertension, 24 untreated patients were challenged with a 2 h euglycaemic hyperinsulinaemic clamp (56 E/m 2 ). Cardiac index (CI) was measured by thoracic impedance cardiography and leg blood flow (LBF) by Doppler ultrasound. During the clamp procedure a significant decline in blood pressure was seen (3.0-5.6% over 120 min, P Ͻ 0.001). However, no significant effects on ejection fraction (+6 ؎ 8 s.d.%), CI (−1 ؎ 2%), heart rate (+2 ؎ 1%) or total peripheral
Introduction
Resistance to the action of insulin with respect to glucose uptake from the circulation has been shown in essential hypertension. 1, 2 However, the ability of insulin to stimulate potassium uptake and to reduce lipid oxidation seems to be intact in hypertensive subjects. 1 Thus, the insulin resistance described in hypertension seems to be selective to certain, but not all, of the actions of insulin.
Insulin can also induce vasodilation. [3] [4] [5] It has been described that this effect of insulin is also impaired in hypertensive subjects. This type of insulin resistance has been described both by measurements of vasodilatation of veins in the hand in hypertensive patients 6 and by blood flow determinations in the leg. 7 A decreased ability of insulin to stimulate peripheral blood flow has been associated with an impaired action of insulin to stimulate peripheral glucose uptake. 5 Therefore, an inability of insulin to dilate blood vessels might be a connecting link between the association between impaired glucose handling and essential hypertension. [8] [9] [10] In the present study, cardiac performance and leg blood flow were followed during a 2 h euglycaemic hyperinsulinaemic clamp in a sample of patients with untreated essential hypertension. It was also investigated if the haemodynamic actions of insulin Correspondence: Dr Lars Lind, Department of Medicine, University Hospital, S-75185 Uppsala, Sweden Received 6 April 1998; revised 25 August 1998; accepted 27 August 1998 resistance (TPRI, −0.5 ؎ 2%) were found. LBF increased by 22 ؎ 35% (P Ͻ 0.005). These haemodynamic effects of insulin were not related to age, sex, body mass index, blood pressure or the insulin-mediated glucose uptake during the clamp. In conclusion, insulin increased LBF, but no changes in CI and TPRI were seen in the hypertensive patients. Furthermore, no association between the ability of insulin to induce vasodilatation and to promote glucose uptake was seen.
were related to the ability to promote glucose uptake in these patients.
Materials and methods
The present study was conducted in 24 hypertensive patients. Five were previously untreated and in 19 patients the antihypertensive treatment was discontinued at least 4 weeks before the present investigation. The known duration of hypertension in the sample was 8 ± 5 s.d. years. Five of the participants were smokers. All investigated subjects were without history of cardiac disorders. All of the hypertensive subjects had in the untreated stage showed a supine diastolic blood pressure (DBP) exceeding 95 mm Hg at repeated visits. Secondary hypertension has been excluded by means of physical examination and standard laboratory tests. Basic characteristics for the hypertensive subjects are shown in Table 1 .
The examinations were performed in the morning after an overnight fast. The euglycaemic hyperinsulinaemic clamp technique according to DeFronzo et al 11 was used. A priming dose of insulin was given for the first 10 min. Thereafter a square wave insulin (Actrapid ® Human: Novo Nordisk, Copenhagen, Denmark) infusion at the rate of 56 mU/m 2 per min was given for 2 h. Glucose was infused i.v. at a variable rate adjusted every 5th minute in order to achieve euglycaemia. The target level of plasma glucose during the clamp study was 5.1 mmol/l. The coefficient of variation for the steady-state plasma glucose concentration was on average 3.4%. The total amount of glucose infused serves as a measure of the subject's sensitivity to infused insulin. The glucose disposal (M-value) during the glucose clamp was calculated on the basis of the amount of glucose infused during the last 60 min of the clamp (mg/kg/min). Body mass index (BMI) was calculated as weight divided by squared height. BP was monitored by an automatic device (OMRON ® HEM 705C, Tokyo, Japan). Stroke volume and heart rate (HR) were monitored by a thoracic bioimpedance cardiograph (BoMed ® NCCOM ® 3 Cardiodynamic Monitor: Irvine, CA, USA) 12 in parallel with the BP recordings. The examination of leg blood flow (LBF) was performed with an Interspec Apogee ™ Ultrasound System (Interspec Inc, Ambler, PA, USA). This system uses two transducers, one for imaging (7.5 MHz) and another for Doppler measurements (5 MHz). Images of the common femoral artery, 2-3 cm proximal to the femoral bifurcation, were obtained. Pulse Doppler examinations were performed at a fixed angle of 60°. The LBF was calculated as the mean of the flow velocity integrals (adjusted for the angle between the sample volume and the vessel wall) obtained during 3-5 beat times the heart rate × by the area of the vessel.
Measurements of BP and central haemodynamics were performed before the start of the euglycaemic hyperinsulinaemic clamp and thereafter every 30 min. LBF was only measured before the start of the clamp and after 120 min.
Mean artery pressure (MAP) was calculated as (systolic BP (SBP) − DBP)/3 + DBP. Total peripheral resistance was calculated from the formula: 80* (MAP − 3)/cardiac output. Central venous pressure was assumed to be 3 mm Hg in all subjects. Both cardiac output and total peripheral resistance were indexed for body surface area to obtain cardiac index (CI) and total peripheral resistance index (TPRI).
Two different groups of healthy, young (20-27 years, 16 females and 19 males) volunteers (BMI 22.4 ± 2.5 kg/m 2 , BP 115 ± 5/77 ± 4 mm Hg) were used for validation of the methods. They were all free from regular medication and a history of cardiovascular or metabolic disorders. In 11 subjects haemodynamic variables were evaluated before and after 2 h of infusion of a saline solution for calculations of the coefficient of variation (CV). It was then found that the CV for HR was 5.1%, CI 2.0%, MAP 2.3%, TPRI 4.6% and for LBF 10%.
Furthermore, 24 volunteers were subjected to an identical protocol as applied in the present study. Plasma insulin increased from a fasting level of 8 ± 3 to 93 ± 9 mU/l. During the hyperinsulinaemic clamp procedure TPRI decreased by 7.5%, CI increased by 6.6%, while MAP was unaffected (−1.2%). Ejection fraction (EF) increased by 5.3% and LBF by 14% during hyperinsulinaemia. All of these changes (except MAP) were significant (P Ͻ 0.01-0.001). This haemodynamic pattern during hyperinsulinaemia is similar to that Baron et al 7 found using a dye dilution technique for measurement of cardiac output and a thermodilution catheter to evaluate LBF.
Changes in haemodynamic variables during the clamp was calculated by means of ANOVA for repeated measurements. Relationship between pairs of variables were calculated by Pearsons' correlation coefficient. Two-tailed significance values are given with P Ͻ 0.05 regarded as significant.
Results
The hyperinsulinaemic clamp increased the fasting insulin levels of 11 ± 5 to 104 ± 27 mU/l after 2 h of insulin infusion. During the clamp procedure a significant decline in MAP was seen (3.0-5.6%, P Ͻ 0.001, see Figure 1 ). However, no significant effects on ejection fraction, CI, heart rate or TPRI were found (see Figures 1 and 2) .
Leg blood flow increased from 1.6 ± 0.5 to 1.9 ± 0.6 dl/min (22%, P Ͻ 0.005). Insulin-mediated glucose uptake during the clamp was not related to LBF during hyperinsulinaemia, the change in LBF during the clamp procedure or to other haemodynamic variables (r = 0.02-0.09).
No significant relationships were found between age and the haemodynamic response to hyperinsulinaemia (r = 0.05-0.07). The three hypertensive patients aged Ͻ30 years were also analysed separately. They showed an even more deviate haemodynamic pattern during the clamp procedure than the rest of the hypertensive group, with a rise in TPRI by 5.3% and a decline in CI by 5.1%. The change in BP was less than 1% in these young hypertensives.
No significant relationships were found between the initial BP level or BMI and the haemodynamic response to hyperinsulinaemia (r = 0.03-0.18).
Discussion
The present study showed that insulin induced vasodilatation in the leg in hypertensive subjects. However, as TPRI was only marginally changed the vasodilatory action of insulin in these hypertensives seemed to be restricted to the limbs. Also the expected rise in cardiac output was blunted in the hypertensive subjects resulting in a decline in BP during hyperinsulinaemia. In addition, no association between the ability of insulin to increase leg blood flow and to promote glucose uptake were seen in this sample of hypertensive patients.
Figure 1
The change in mean arterial blood pressure (MAP) and heart rate during the 2-h euglycaemic hyperinsulinaemic clamp. Mean and s.e.m. are given. The change in MAP, but not that in heart rate, is significant (P Ͻ 0.001 with ANOVA for repeated measurements).
In the resting state limb blood flow accounts for 5-10% of cardiac output. In the hypertensives LBF increased by 22% while TPRI remained virtually unchanged, except for a transient non-significant decline during the first 30 min of the clamp. In healthy man, hyperinsulinaemia has been shown to induce vasodilatation in the kidney. 13 At a similar insulin level as in the present study renal plasma flow increased by 10% during insulin clamping. 13 As total blood flow through the kidneys exceeds limb blood flow, the ability to induce vasodilatation in the renal vascular beds are of primary importance for TPRI. The action of insulin on renal blood flow has not been studied in hypertensive subjects. The findings in the present study suggest that it would be of interest to study this matter.
The mechanism whereby insulin induces vasodilatation is not fully understood. Previous studies have shown that pretreatment with blockers of nitric oxide (NO) production blunted the vasodilatory effect of insulin. 14, 15 It has previously been shown that endothelium-dependent vasodilatation is impaired in hypertensive subjects. 16, 17 It therefore seems likely that a defect in the NO-system plays a role in the blunted effect of insulin on TPRI seen in this sample of hypertensive subjects.
Another factor involved in the haemodynamic response to insulin is an activation of the sympathetic nervous system. The activation of the sympathetic nervous system during insulin stimulation has been recorded both by measurements of circulating cathecholamines and by measurements of sympathetic nerve activity. 18, 19 This action of insulin seems to be centrally mediated as it could be abolished by destruction of the antero-ventral part of the thalamus in experimental animals. 20 If the stimulatory effect of insulin on sympathetic nerve activity modulates, the haemodynamic effects of insulin in hypertensive subjects remains to be examined.
In the hypertensive subjects the initial transient drop in TPRI was not associated with an increase in cardiac index, resulting in a decline in BP. This lack in myocardial response to vasodilatation could be due to an impaired baroreceptor reflex. However, in experimental animals insulin has been shown to possess an inotropic action. 21 It may well be that the hypertensive heart also is resistant to a presumed inotropic action of insulin.
The ability of insulin to stimulate glucose uptake is known to decline with age. 22, 24 However, no relationship between age and the haemodynamic changes induced by hyperinsulinaemia were found in the hypertensive group. In fact, in the three young hypertensive subjects no vasodilatation was seen and they showed an even more deviant haemodynamic pattern than in the older hypertensives. Thus, the haemodynamic response to hyperinsulinaemia seen in the hypertensives is most likely not merely an effect of ageing.
In a recent study insulin induced an attenuated vasodilatation in the veins in the hand in hypertensive subjects. 6 In that study obesity was also a major factor involved in the impaired haemodynamic response to insulin. It has also been shown by blood flow determinations both by the thermodilution technique and by venous occlusion plethysmography that the ability of insulin to induce vasodilatation is impaired in obese normotensive subjects. 3, 4 In the present study, the majority of hypertensive subjects were overweight, but no relationships were found between BMI and the haemodynamic changes during the clamp.
It is a matter of dispute whether or not the vasodilatory properties of insulin contribute to glucose uptake. 3, 7, 25, 26 In the present study vasodilatation in the leg induced by hyperinsulinaemia was not related to insulin-mediated glucose uptake. Thus, at least in hypertensive subjects leg blood flow does not seem to be a major determinant of glucose uptake.
The thoracic bioimpedance technique has improved during recent years both in terms of the measured signal and in computing software 12 and could nowadays be safely used to study changes within individuals. The finding that hyperinsulinaemia induced a highly significant increase in CI and a parallel decline in TPRI in young healthy subjects is in accordance with a study using the dye dilution technique. 7 We have also shown that infusion with noradrenaline induced the expected changes in haemodynamics when evaluated with the thoracic bioimpedance technique. 27 In the present study no age and obesity-matched control group was investigated and any comparison with the young lean controls should be performed by caution. This control group was investigated in order to validate the experimental set-up and to explore the physiological effects of insulin in healthy subjects.
In conclusion, insulin increased LBF, but no changes in CI and TPRI were seen in the hypertensive patients. This might indicate a decreased ability of insulin to induce vasodilatation in other vascular beds than those found in the leg in hypertensive subjects. Furthermore, no association between the ability of insulin to induce vasodilatation and to promote glucose uptake was seen in this group of patients.
